Skip Nav Destination
Issues
1 December 2016
-
Cover Image
Cover Image
Adoptive cell transfer (ACT) of tumor-specific Th2 cells is a highly efficient immunotherapy protocol against cancer in mice. Immunofluorescence microscopy revealed that Th2 ACT induced expression of arginase (red) by tumor-infiltrating macrophages (green). Cell nuclei are stained blue. Arginase was shown to be critical for cancer eradication by Th2 cells. For details, see article by Lorvik and colleagues on page 6864. - PDF Icon PDF LinkTable of Contents
- PDF Icon PDF LinkEditorial Board
ISSN 0008-5472
EISSN 1538-7445
Issue Sections
Journal Archive
Cancer Research (1941-Present; volumes 1-current)
(ISSN 0008-5472) Published twice monthly since 1987. From 1941-1986, published monthly.The American Journal of Cancer (1931-1940; volumes 15-40)
(ISSN 0099-7374) Published quarterly in 1931, bimonthly in 1932, and monthly from 1933 to 1940. The journal changed title to Cancer Research in 1941.The Journal of Cancer Research (1916-1930); volumes 1-14)
(ISSN 0099-7013) Published quarterly from 1916 through 1930 (publication was suspended from November 1922 to March 1924). The journal changed title to The American Journal of Cancer in 1931.Table of Contents
Breaking Advances
Cancer Research 75th Anniversary Commentaries
Perspective
Meeting Report
Priority Report
Integrated Systems and Technologies
Microenvironment and Immunology
Author Choice
Regeneration of CD8αβ T Cells from T-cell–Derived iPSC Imparts Potent Tumor Antigen-Specific Cytotoxicity
Takuya Maeda; Seiji Nagano; Hiroshi Ichise; Keisuke Kataoka; Daisuke Yamada; Seishi Ogawa; Haruhiko Koseki; Toshio Kitawaki; Norimitsu Kadowaki; Akifumi Takaori-Kondo; Kyoko Masuda; Hiroshi Kawamoto
Author Choice
Chemoresistance in Pancreatic Cancer Is Driven by Stroma-Derived Insulin-Like Growth Factors
Lucy Ireland; Almudena Santos; Muhammad S. Ahmed; Carolyn Rainer; Sebastian R. Nielsen; Valeria Quaranta; Ulrike Weyer-Czernilofsky; Danielle D. Engle; Pedro A. Perez-Mancera; Sarah E. Coupland; Azzam Taktak; Thomas Bogenrieder; David A. Tuveson; Fiona Campbell; Michael C. Schmid; Ainhoa Mielgo
Molecular and Cellular Pathobiology
Transcription Factor ZBP-89 Drives a Feedforward Loop of β-Catenin Expression in Colorectal Cancer
Bryan E. Essien; Sinju Sundaresan; Ramon Ocadiz-Ruiz; Aaron Chavis; Amy C. Tsao; Arthur J. Tessier; Michael M. Hayes; Amanda Photenhauer; Milena Saqui-Salces; Anthony J. Kang; Yatrik M. Shah; Balazs Győrffy; Juanita L. Merchant
Cell Adhesion Molecule CD166 Drives Malignant Progression and Osteolytic Disease in Multiple Myeloma
Linlin Xu; Khalid S. Mohammad; Hao Wu; Colin Crean; Bradley Poteat; Yinghua Cheng; Angelo A. Cardoso; Christophe Machal; Helmut Hanenberg; Rafat Abonour; Melissa A. Kacena; John Chirgwin; Attaya Suvannasankha; Edward F. Srour
Author Choice
mTORC2 Signaling Drives the Development and Progression of Pancreatic Cancer
David R. Driscoll; Saadia A Karim; Makoto Sano; David M. Gay; Wright Jacob; Jun Yu; Yusuke Mizukami; Aarthi Gopinathan; Duncan I. Jodrell; T.R. Jeffry Evans; Nabeel Bardeesy; Michael N. Hall; Brian J. Quattrochi; David S. Klimstra; Simon T. Barry; Owen J. Sansom; Brian C. Lewis; Jennifer P. Morton
Therapeutics, Targets, and Chemical Biology
High-Order Drug Combinations Are Required to Effectively Kill Colorectal Cancer Cells
Thomas Horn; Stéphane Ferretti; Nicolas Ebel; Angela Tam; Samuel Ho; Fred Harbinski; Ali Farsidjani; Matthew Zubrowski; William R. Sellers; Robert Schlegel; Dale Porter; Erick Morris; Jens Wuerthner; Sébastien Jeay; Joel Greshock; Ensar Halilovic; Levi A. Garraway; Giordano Caponigro; Joseph Lehár
Tumor-Intrinsic PD-L1 Signals Regulate Cell Growth, Pathogenesis, and Autophagy in Ovarian Cancer and Melanoma
Curtis A. Clark; Harshita B. Gupta; Gangadhara Sareddy; Srilakshmi Pandeswara; Shunhua Lao; Bin Yuan; Justin M. Drerup; Alvaro Padron; José Conejo-Garcia; Kruthi Murthy; Yang Liu; Mary Jo Turk; Kathrin Thedieck; Vincent Hurez; Rong Li; Ratna Vadlamudi; Tyler J. Curiel
Author Choice
Genetic Polymorphisms in the Long Noncoding RNA MIR2052HG Offer a Pharmacogenomic Basis for the Response of Breast Cancer Patients to Aromatase Inhibitor Therapy
James N. Ingle; Fang Xie; Matthew J. Ellis; Paul E. Goss; Lois E. Shepherd; Judith-Anne W. Chapman; Bingshu E. Chen; Michiaki Kubo; Yoichi Furukawa; Yukihide Momozawa; Vered Stearns; Kathleen I. Pritchard; Poulami Barman; Erin E. Carlson; Matthew P. Goetz; Richard M. Weinshilboum; Krishna R. Kalari; Liewei Wang
TRPA1 Mediates Aromatase Inhibitor–Evoked Pain by the Aromatase Substrate Androstenedione
Francesco De Logu; Raquel Tonello; Serena Materazzi; Romina Nassini; Camilla Fusi; Elisabetta Coppi; Simone Li Puma; Ilaria M. Marone; Laura R. Sadofsky; Alyn H. Morice; Tommaso Susini; Alessandro Terreni; Gloriano Moneti; Mariarosaria Di Tommaso; Pierangelo Geppetti; Silvia Benemei
Tumor and Stem Cell Biology
Oncogenic Functions of Gli1 in Pancreatic Adenocarcinoma Are Supported by Its PRMT1-Mediated Methylation
Yan Wang; Jung-Mao Hsu; Ya'an Kang; Yongkun Wei; Pei-Chih Lee; Shing-Jyh Chang; Yi-Hsin Hsu; Jennifer L. Hsu; Hung-Ling Wang; Wei-Chao Chang; Chia-Wei Li; Hsin-Wei Liao; Shih-Shin Chang; Weiya Xia; How-Wen Ko; Chao-Kai Chou; Jason B. Fleming; Huamin Wang; Rosa F. Hwang; Yue Chen; Jun Qin; Mien-Chie Hung
Correction
Advertisement
Email alerts
NOTICE: This notice serves to inform the reader that, in 2023, AACR received a donation by Pfizer of the rights to royalties from the sale within the United States of Bavencio® (avelumab), a pharmaceutical owned by Merck. If any resulting funds are received, they would not be used to directly support any specific publication or author. If an individual article is published that deals with this particular drug, such article will include standard financial disclosures per AACR journal policy. For more detail regarding AACR’s established policies for authors, please go to https://aacrjournals.org/pages/editorial-policies#coi.
RSS Feeds